Advanced Treatment Medicinal Products (ATMPs) are innovative treatments aimed at severe diseases. However, patient access varies across European countries. The present research reviews the reimbursement status of the licensed ATMPs in England, Scotland, France, Germany, Italy, Spain, Ireland, Denmark and Sweden and aim...
Paraskevi M. Georgiou, K. Athanasakis· Discover Health Systems· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.